Sign in

CIK 0001815974 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Anebulo Pharmaceuticals, Inc.

Sign in to watch
Ticker
ANEB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
operating
EIN
851170950
Phone
737 203 5270
Business address
C/O ANEBULO PHARMACEUTICALS, INC., 1017 RANCH ROAD 620 SOUTH, SUITE 107, LAKEWAY, TX, 78734
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-12-23 English Aron R. Director Purchase +10,101,010 $0.99 $10.0M 15,467,300
2021-12-17 English Aron R. Director Purchase +400 $6.59 $3K 3,362,713
2021-12-14 English Aron R. Director Purchase +412 $5.90 $2K 3,362,313
2021-12-03 English Aron R. Director Purchase +4,500 $5.93 $27K 3,361,901
2021-12-02 English Aron R. Director Purchase +13,836 $5.30 $73K 3,357,401

Page 1 of 1 · 5 trades